Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:43:13 EDT Fri 17 May 2024
Enter Symbol
or Name
USA
CA



News for U:MTEM from 2023-05-18 to 2024-05-17 - 17 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-15 17:12U:MTEMNews ReleaseMolecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update
2024-04-09 08:11U:MTEMNews ReleaseMolecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patie
2024-03-29 08:21U:MTEMNews ReleaseMolecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
2024-03-28 08:11U:MTEMNews ReleaseMolecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement
2024-03-04 08:11U:MTEMNews ReleaseMolecular Templates, Inc. Provides Interim Update
2024-02-08 17:55U:MTEMNews ReleaseMolecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
2023-11-13 16:11U:MTEMNews ReleaseMolecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update
2023-11-02 16:11U:MTEMNews ReleaseMolecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors
2023-11-01 16:12U:MTEMNews ReleaseMolecular Templates to Participate in Upcoming Investor Conferences
2023-09-28 16:11U:MTEMNews ReleaseMolecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer
2023-08-11 11:22U:MTEMNews ReleaseMolecular Templates Announces 1-for-15 Reverse Stock Split
2023-08-10 08:08U:MTEMNews ReleaseMolecular Templates, Inc. Reports Second Quarter 2023 Financial Results and Business Update
2023-08-02 16:11U:MTEMNews ReleaseMolecular Templates Announces Executive Leadership Changes
2023-07-13 08:14U:MTEMNews ReleaseMolecular Templates Announces Up to $40 Million Private Placement Offering
2023-06-16 20:56U:MTEMNews ReleaseMolecular Templates Announces Debt Payoff and Restructuring
2023-06-01 07:57U:MTEMNews ReleaseMolecular Templates Announces the FDA Removal of Partial Clinical Hold in the Phase 1 Clinical Trial for MT-0169 and Focuses on Extramedullary Myeloma
2023-05-26 17:10U:MTEMNews ReleaseMolecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting